OBIO is proud to partner with the Ontario Institute for Regenerative Medicine (OIRM), the Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine (C3i), BioInnovation Fund, Bloom Burton & Co., and Versant Ventures to ensure made-in-Ontario technologies get the strategic support they need to succeed.
Kick-Start will support successful applicants with resources to create an incorporated business, along with market assessments and an IP/commercialization plan. Investment funding of up to $100,000 and expert guidance from partners will help researcher attract early-stage investment and build value for the new company. The program will also link applicants with investors and other private sector expertise needed to attract funding and to develop and market the proposed technology.